Last deal

$45M

Amount

Series B

Stage

21.08.2024

Date

2

all rounds

$75M

Total amount

General

About Company
XII Medical offers a minimally invasive solution for obstructive sleep apnea.

Industry

Sector :

Subsector :

Also Known As

Enhale Medical

founded date

01.01.2017

Number of employees

Last funding type

Series B

IPO status

Private

Description

The medical device developer has created an outpatient technology that treats the condition in a minimally invasive way. This solution is designed to be used outside of a hospital setting, making it more accessible to patients. XII Medical's technology is aimed at providing a more comfortable and convenient alternative to traditional treatments for obstructive sleep apnea.
Contacts

Phone number

Social url